The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...

Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.

Johnson & Johnson infused positive optimism after posting solid third-quarter 2024 earnings. A few analysts raised their ...

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Leerink Partners analyst David Risinger has maintained their bullish stance on ANAB stock, giving a Buy rating yesterday. David Risinger has ...

J&J has said it will now need upfront payment in full for its anticoagulant Xarelto (rivaroxaban) and immunology therapy Stelara (ustekinumab), with a rebate paid later, rather than the previous ...

A murder investigation has been launched in the disappearance of Kyran Durnin, from Drogheda, Co Louth. His 24-year-old mother Dayla Durnin has since been found alive in the UK, according to the ...

October 17, 2024 • During a town hall outside Miami, Trump touted his record on the economy, yet called Jan. 6 a "day of love" and would not back off false claims about Haitian migrants eating ...

It's the latest defeat for allies of Donald Trump seeking to change how the battleground state's votes are counted in the Nov. 5 presidential election.

Chief Justice of India, D.Y. Chandrachud, has proposed Justice Sanjiv Khanna as his successor. Justice Khanna, appointed to the Supreme Court in 2019, is set to become the 51st CJI upon government ...